| P2093 | author name string | Panagiota Georgiadou | |
| | Stamatis Adamopoulos | |
| P2860 | cites work | Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure | Q61776489 |
| | Alterations of skeletal muscle in chronic heart failure | Q67487930 |
| | Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity | Q68004599 |
| | Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure | Q68698026 |
| | 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure | Q69186240 |
| | Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure | Q69566717 |
| | Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure | Q69778142 |
| | Physical training improves skeletal muscle metabolism in patients with chronic heart failure | Q70625396 |
| | Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training | Q70993117 |
| | Rat skeletal muscle metabolism in experimental heart failure: effects of physical training | Q71548644 |
| | Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function | Q73509565 |
| | Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure | Q73595578 |
| | The effect of physical training on skeletal muscle in patients with chronic heart failure | Q73609000 |
| | Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance | Q74635681 |
| | Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle | Q77958718 |
| | Female-related skeletal muscle phenotype in patients with moderate chronic heart failure before and after dynamic exercise training | Q78091819 |
| | Impaired capillary hemodynamics in skeletal muscle of rats in chronic heart failure | Q78117895 |
| | How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH | Q78482942 |
| | Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure | Q81003444 |
| | Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure | Q24646933 |
| | Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 |
| | Differences in skeletal muscle between men and women with chronic heart failure | Q31777033 |
| | Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction | Q33220571 |
| | Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure | Q33919515 |
| | Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. | Q34697114 |
| | Chronic heart failure and skeletal muscle catabolism: effects of exercise training | Q34774460 |
| | Metabolic myopathy in heart failure | Q34882722 |
| | Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications | Q35162695 |
| | Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) | Q35253389 |
| | Peripheral abnormalities in chronic heart failure. | Q37400620 |
| | Chronic heart failure and exercise intolerance: the hemodynamic paradox | Q37425912 |
| | Cachexia versus sarcopenia | Q37809432 |
| | Respiratory muscle dysfunction and training in chronic heart failure. | Q37857512 |
| | Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions | Q40364656 |
| | Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway | Q40490374 |
| | Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance | Q43495134 |
| | Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure | Q43790684 |
| | Cardiac and skeletal muscle energy metabolism in heart failure: Beneficial effects of voluntary activity | Q44189221 |
| | Skeletal muscle reflex in heart failure patients: role of hydrogen. | Q44285211 |
| | Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure | Q45098718 |
| | Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure | Q46699229 |
| | Functional and morphological skeletal muscle abnormalities correlate with reduced electromyographic activity in chronic heart failure | Q47369561 |
| | B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure | Q48968444 |
| | Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weakness. | Q48973575 |
| | Increased plasma myostatin in heart failure. | Q51581859 |
| | Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis. | Q51752159 |
| | Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. | Q53975324 |
| | Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. | Q54756905 |
| | Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure | Q57422772 |
| P433 | issue | 2 | |
| P921 | main subject | chronic heart failure | Q11829287 |
| | heart failure | Q181754 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 128-132 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Current heart failure reports | Q26842297 |
| P1476 | title | Skeletal muscle abnormalities in chronic heart failure | |
| P478 | volume | 9 | |